Skip to main navigation Skip to search Skip to main content

Delayed orchiectomy after chemotherapy for metastatic nonseminomatous germ cell tumors

  • Ilan Leibovitch*
  • , J. Samuel Little
  • , Richard S. Foster
  • , Randall G. Rowland
  • , Richard Bihrle
  • , John P. Donohue
  • *Corresponding author for this work
  • Indiana University-Purdue University Indianapolis

Research output: Contribution to journalArticlepeer-review

48 Scopus citations

Abstract

Purpose: We reviewed current experience at our university with delayed orchiectomy after chemotherapy in patients with metastatic nonseminomatous germ cell tumors. Materials and Methods: We retrospectively analyzed the records of 160 patients with metastatic germ cell cancer who were given systemic chemotherapy, and subsequently underwent orchiectomy and retroperitoneal lymph node dissection. Results: Analysis of 160 testicular specimens revealed necrosis or scar in 70 (43.7%), pure teratoma in 50 (31.2%) and persistent germ cell cancer in 40 (25%). Corresponding incidences of histopathological findings in the post-chemotherapy retroperitoneal lymph node dissection specimens were significantly different, correlating with less than half of the cases (chi-square, p = 0.002). Conclusions: Our study confirms the need for delayed orchiectomy after systemic chemotherapy even when there seems to be a partial or complete clinical response at other sites.

Original languageEnglish
Pages (from-to)952-954
Number of pages3
JournalJournal of Urology
Volume155
Issue number3
DOIs
StatePublished - Mar 1996
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • drug therapy
  • orchiectomy
  • testicular neoplasms
  • testis

Fingerprint

Dive into the research topics of 'Delayed orchiectomy after chemotherapy for metastatic nonseminomatous germ cell tumors'. Together they form a unique fingerprint.

Cite this